What “Meropenem process” patent applications usually mean
A “meropenem process” patent application typically covers how to manufacture meropenem (or a specific meropenem intermediate) rather than the drug itself. These applications are often aimed at improving yield, purity, reaction conditions, solvent selection, or steps used to convert key intermediates into meropenem.
Where to look for the exact application
To find the specific meropenem process patent application you mean, you usually need at least one of these details:
- applicant/company name (e.g., a generic manufacturer)
- application or publication number
- filing country/office (e.g., USPTO, EPO, India, etc.)
- the assignee listed on the publication
- an intermediate or process keyword from the title
If you share any of the above, I can narrow it to the correct published application and summarize what the claim set is trying to protect.
How “process” patents relate to generic meropenem approvals
Process patents can still matter even after drug substance patents expire, because they can cover manufacturing methods used by generic entrants. If a generic company uses a process that falls within the claims, that can drive patent challenges, licensing, or litigation.
Can you tell me the jurisdiction or publication number?
“Meropenem process us patent application” could refer to many different US filings. If you provide the patent publication number (for example, something like US 20xx/xxxxx), I can:
- identify the filing date and assignee
- explain the manufacturing steps described
- highlight the claim scope at a practical level
How DrugPatentWatch.com can help
DrugPatentWatch.com tracks patent and exclusivity information for drug products and can help you map relevant patent activity. You can use it to search meropenem and then drill into process-related filings tied to specific assignees and jurisdictions: https://www.drugpatentwatch.com/
---
Quick question so I can answer precisely
Which US patent application are you referring to—do you have a publication number (US 20xx/xxxxxx) or the company/applicant name?